These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 11254872)
21. [Sequential analysis of p210- and p190-bcr-abl by RT-PCR after allogeneic bone marrow transplantation for p210/p190-bcr-abl double positive acute lymphoblastic leukemia]. Fujimaki K; Maruta A; Yoshida M; Yamazaki E; Motomura S; Kodama F; Matsuzaki M; Fujisawa S; Kanamori H; Ishigatsubo Y Rinsho Ketsueki; 2001 Feb; 42(2):89-93. PubMed ID: 11280922 [TBL] [Abstract][Full Text] [Related]
22. A farnesyltransferase inhibitor increases survival of mice with very advanced stage acute lymphoblastic leukemia/lymphoma caused by P190 Bcr/Abl. Mishra S; Zhang B; Groffen J; Heisterkamp N Leukemia; 2004 Jan; 18(1):23-8. PubMed ID: 14603339 [TBL] [Abstract][Full Text] [Related]
23. Bcr: a negative regulator of the Bcr-Abl oncoprotein in leukemia. Arlinghaus RB Oncogene; 2002 Dec; 21(56):8560-7. PubMed ID: 12476302 [TBL] [Abstract][Full Text] [Related]
24. Leukemogenesis of b2a2-type p210 BCR/ABL in a bone marrow transplantation mouse model using a lentiviral vector. Uchida N; Hanawa H; Dan K; Inokuchi K; Shimada T J Nippon Med Sch; 2009 Jun; 76(3):134-47. PubMed ID: 19602820 [TBL] [Abstract][Full Text] [Related]
25. Inhibition of the Bcr-Abl oncoprotein by Bcr requires phosphoserine 354. Hawk N; Sun T; Xie S; Wang Y; Wu Y; Liu J; Arlinghaus RB Cancer Res; 2002 Jan; 62(2):386-90. PubMed ID: 11809685 [TBL] [Abstract][Full Text] [Related]
26. Bcr/Abl P190 interaction with Spa-1, a GTPase activating protein for the small GTPase Rap1. Yi SJ; Lee HT; Groffen J; Heisterkamp N Int J Mol Med; 2008 Oct; 22(4):453-8. PubMed ID: 18813851 [TBL] [Abstract][Full Text] [Related]
27. Nilotinib treatment in mouse models of P190 Bcr/Abl lymphoblastic leukemia. Kaur P; Feldhahn N; Zhang B; Trageser D; Müschen M; Pertz V; Groffen J; Heisterkamp N Mol Cancer; 2007 Oct; 6():67. PubMed ID: 17958915 [TBL] [Abstract][Full Text] [Related]
28. Invadopodia and rolling-type motility are specific features of highly invasive p190(bcr-abl) leukemic cells. Daubon T; Rochelle T; Bourmeyster N; Génot E Eur J Cell Biol; 2012; 91(11-12):978-87. PubMed ID: 22717125 [TBL] [Abstract][Full Text] [Related]
29. A BCR-ABL(p190) fusion gene made by homologous recombination causes B-cell acute lymphoblastic leukemias in chimeric mice with independence of the endogenous bcr product. Castellanos A; Pintado B; Weruaga E; Arévalo R; López A; Orfao A; Sánchez-García I Blood; 1997 Sep; 90(6):2168-74. PubMed ID: 9310467 [TBL] [Abstract][Full Text] [Related]
30. Multiplex in-cell reverse transcription-polymerase chain reaction for the simultaneous detection of p210 and p190 BCR-ABL mRNAs in chronic myeloid leukemia and Philadelphia-positive acute lymphoblastic leukemia cell lines. Suh SP; Kee SJ; Lim WH; Song JW; Lee SK; Kim JP; Shin JH; Ryang DW Clin Chem Lab Med; 2000 Sep; 38(9):939-44. PubMed ID: 11097354 [TBL] [Abstract][Full Text] [Related]
31. The function of BCR/ABL and related proto-oncogenes. Gotoh A; Broxmeyer HE Curr Opin Hematol; 1997 Jan; 4(1):3-11. PubMed ID: 9050373 [TBL] [Abstract][Full Text] [Related]
32. Vav3 collaborates with p190-BCR-ABL in lymphoid progenitor leukemogenesis, proliferation, and survival. Chang KH; Sanchez-Aguilera A; Shen S; Sengupta A; Madhu MN; Ficker AM; Dunn SK; Kuenzi AM; Arnett JL; Santho RA; Agirre X; Perentesis JP; Deininger MW; Zheng Y; Bustelo XR; Williams DA; Cancelas JA Blood; 2012 Jul; 120(4):800-11. PubMed ID: 22692505 [TBL] [Abstract][Full Text] [Related]
33. Generation of rac3 null mutant mice: role of Rac3 in Bcr/Abl-caused lymphoblastic leukemia. Cho YJ; Zhang B; Kaartinen V; Haataja L; de Curtis I; Groffen J; Heisterkamp N Mol Cell Biol; 2005 Jul; 25(13):5777-85. PubMed ID: 15964830 [TBL] [Abstract][Full Text] [Related]
34. Characterization of p190-Bcr-Abl chronic myeloid leukemia reveals specific signaling pathways and therapeutic targets. Adnan-Awad S; Kim D; Hohtari H; Javarappa KK; Brandstoetter T; Mayer I; Potdar S; Heckman CA; Kytölä S; Porkka K; Doma E; Sexl V; Kankainen M; Mustjoki S Leukemia; 2021 Jul; 35(7):1964-1975. PubMed ID: 33168949 [TBL] [Abstract][Full Text] [Related]
35. P190-type bcr/abl expressed in myeloid colonies in a patient with Ph1-positive acute lymphoblastic leukemia. Sadamura S; Umemura T; Hirata J; Takahira H; Yufu Y; Abe Y; Nishimura J; Nawata H Leukemia; 1992 Aug; 6(8):791-5. PubMed ID: 1640730 [TBL] [Abstract][Full Text] [Related]
36. [The relationship between the persistence of the BCR/ABL gene and relapse in adult patients with acute lymphoblastic leukemia]. Anguita E; Villegas A; González FA; del Potro E; Martínez R; Alvarez A; Díaz-Mediavilla J; Ferro MT; Espinós D Med Clin (Barc); 1999 Apr; 112(13):481-4. PubMed ID: 10353112 [TBL] [Abstract][Full Text] [Related]
37. BCR sequences essential for transformation by the BCR-ABL oncogene bind to the ABL SH2 regulatory domain in a non-phosphotyrosine-dependent manner. Pendergast AM; Muller AJ; Havlik MH; Maru Y; Witte ON Cell; 1991 Jul; 66(1):161-71. PubMed ID: 1712671 [TBL] [Abstract][Full Text] [Related]
38. Subcellular localization of Bcr, Abl, and Bcr-Abl proteins in normal and leukemic cells and correlation of expression with myeloid differentiation. Wetzler M; Talpaz M; Van Etten RA; Hirsh-Ginsberg C; Beran M; Kurzrock R J Clin Invest; 1993 Oct; 92(4):1925-39. PubMed ID: 8408645 [TBL] [Abstract][Full Text] [Related]
40. Effect of Bcr sequences on the cellular function of the Bcr-Abl oncoprotein. McWhirter JR; Wang JY Oncogene; 1997 Oct; 15(14):1625-34. PubMed ID: 9349495 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]